The relation between striatal dopamine D2/D3 receptor availability and sleep quality in healthy adults

Nuclear Medicine Communications

Volumn 28, Issue 5, 2007, Pages 401-406

  Lee, Bi Fang ^a   Chiu, Nan Tsing ^a   Kuang Yang, Yen ^b   Lin Chu, Ching ^b  

^a Departments of Nuclear Medicine   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Caudate nucleus; Dopamine receptors; Healthy adults; Sleep quality; SPECT

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE 1 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; NORMAL HUMAN; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP; STATISTICAL SIGNIFICANCE;

ADULT; CORPUS STRIATUM; FEMALE; HUMANS; MALE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SLEEP;

EID: 34147139525     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3280bad8b6     Document Type: Article

References (39)

1. Miller JD, Farber J, Gatz P, Roffwarg H, German DC. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res 1983; 273:133-141.
2. Steinfels GF, Heym J, Strecker RE, Jacobs BL. Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 1983; 258:217-228.
3. Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Sleep attacks and Parkinson's disease treatment. Lancet 2000; 355:1333-1334.
4. Andreu N, Chale JJ, Senard JM, Thalamas C, Montastruc JL, Rascol O. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol 1999; 22:15-23.
5. Wiegand M, Moller AA, Lauer CJ, Stolz S, Schreiber W, Dose M, et al. Nocturnal sleep in Huntington's disease. J Neurol 1991; 238:203-208.
6. Sheehan DV, Lecrubier Y, Sheehan KH, Amorin P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (suppl):22-33; quiz, 34-57.
7. Cheng TA, Williams P. The design and development of a screening questionnaire (CHQ) for use in community studies of mental disorders in Taiwan. Psychol Med 1986; 16:415-422.
8. rd CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193-213.
9. Chen ML, Lin LC, Wu SC, Lin JG. The effectiveness of acupressure in improving the quality of sleep of institutionalized residents. J Gerontol A Biol Sci Med Sci 1999; 54:M389-M394.
10. Yang YK, Chiu NT, Chen CC, Chen M, Yeh TL, Lee IH. Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls. Psychiatry Res 2003; 123:191-197.
11. Parsey RV, Oquendo MA, Zea-Ponce Y, Rodenhiser J, Kegeles LS, Pratap M, et al. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry 2001; 50:313-322.
12. Gillin C, van Kammen DP, Post RM, Sitaram N, Wyatt RJ, Bunney WE. What is the role of dopamine in the regulation of sleep-wake activity? In: Corsini GU, Gessa GL, editors: Apomorphine and Other Dopamimetics. New York: Raven Press; 1981, pp. 157-164.
13. Deniau JM, Chevalier G. Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res 1985; 334:227-233.
14. Nishino S, Mao J, Sampathkumaran R, Shelton J. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online 1998; 1:49-61.
15. Isaac SO, Berridge CW. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. J Pharmacol Exp Ther 2003; 307:386-394.
16. Trulson ME. Simultaneous recording of substantia nigra neurons and voltammetric release of dopamine in the caudate of behaving cats. Brain Res Bull 1985; 15:221-223.
17. Decker M, Keating GL, Freeman AA, Rye DB. Parkinsonian-like sleep-wake architecture in rats with bilateral striatal 6-OHDA lesions. Soc Neurosci Abstr 2000; 26:1514.
18. Mena-Segovia J, Cintra L, Prospero-Garcia O, Giordano M. Changes in sleep-waking cycle after striatal excitotoxic lesions. Behav Brain Res 2002; 136:475-481.
19. Mena-Segovia J, Giordano M. Striatal dopaminergic stimulation produces c-Fos expression in the PPT and an increase in wakefulness. Brain Res 2003; 986:30-38.
20. Bagetta G, De Sarro G, Priolo E, Nistico G. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Br J Pharmacol 1988; 95:860-866.
21. Monti JM, Hawkins M, Jantos H, D'Angelo L, Fernandez M. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 1988; 95:395-400.
22. Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 2002; 3:932-942.
23. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990; 5:280-285.
24. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002; 58:341-346.
25. Chaudhuri KR, Pal S, Brefel-Courbon C. ‘Sleep attacks’ or ‘unintended sleep episodes’ occur with dopamine agonists: is this a class effect? Drug Safety 2002; 25:473-483.
26. Bjorklund A, Lindall O. Handbook of Chemical Neuroanatomy, vol 2: Amsterdam: Elsevier Science Publishers; 1984.
27. Bassi S, Albizzati MG, Frattola L, Passerini D, Trabucchi M. Dopamine receptors and sleep induction in man. J Neurol Neurosurg Psychiatry 1979; 42:458-460.
28. Ferreira JJ, Galitzky M, Thalamas C, Tiberge M, Montastruc JL, Sampaio C, et al. Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology 2002; 58:460-462.
29. Parent A. Extrinsic connections of the basal ganglia. TINS 1990; 13:254-258.
30. Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9:357-381.
31. Kanbayashi T, Honda K, Kodama T, Mignot E, Nishino S. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy. Neuroscience 2000; 99:651-659.
32. Balkin TJ, Braun AR, Wesensten NJ, Jeffries K, Varga M, Baldwin P, et al. The process of awakening: a PET study of regional brain activity patterns mediating the re-establishment of alertness and consciousness. Brain 2002; 125:2308-2319.
33. Lang AE, Lozano AM. Parkinson's disease. New Engl J Med 1998; 339:1044-1053.
34. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002; 58:1544-1546.
35. Mendelson WB. Neurotransmitters and sleep. J Clin Psychiatry 2001; 10:5-8.
36. Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 2002; 53:737-740.
37. Curcio G, Ferrara M, Piergianni A, Fratello F, De Gennaro L. Paradoxes of the first-night effect: a quantitative analysis of antero-posterior EEG topography. Clin Neurophysiol 2004; 115:1178-1188.
38. Fictenberg NL, Putnam SH, Mann NR, Zafonte RD, Millard AE. Insomnia screening in postacute traumatic brain injury: utility and validity of the Pittsburgh Sleep Quality Index. Am J Phys Med Rehabil 2001; 80:339-345.
39. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000; 3:423-451.